Correction: Tian et al. Diaporine Potentiates the Anticancer Effects of Oxaliplatin and Doxorubicin on Liver Cancer Cells. J. Pers. Med. 2022, 12, 1318

By afschroeder • February 27, 2026

Tian S, Su R, Wu K, Zhou X, Vadgama JV, Wu Y. Correction: Tian et al. Diaporine Potentiates the Anticancer Effects of Oxaliplatin and Doxorubicin on Liver Cancer Cells. J. Pers. Med. 2022, 12, 1318. J Pers Med. 2026 Feb 9;16(2):101. doi: 10.3390/jpm16020101. Erratum for: J Pers Med. 2022 Aug 16;12(8):1318. doi: 10.3390/jpm12081318. PMID: 41745417; PMCID: PMC12941905.

Tags: General Internal Medicine, King Drew Med Ctr, Publications

State-level paid sick leave: impacts of policy design on access by immigrant workers

Luo Z, Sprague A, McCormack M, Heymann J. State-level paid sick leave: impacts of policy design on access by immigrant workers. Health Aff Sch. 2026[...]

Multiorgan Toxicity Following Rifapentine and Isoniazid Therapy for Latent Tuberculosis Infection: A Case Report

Parvini Najafabadi S, Ramesh K, Tu B, Fiske B, Meyer N. Multiorgan Toxicity Following Rifapentine and Isoniazid Therapy for Latent Tuberculosis Infection: A Case Report.[...]

Effects of Empagliflozin on Cardiovascular Outcomes Are Consistent Across Sociodemographic Subgroups: A Real-World Analysis From the EMPRISE Study

Cromer SJ, Tesfaye H, Cho H, Wexler DJ, Ortega-Montiel J, Schmedt N, Shay CM, Paik JM, Patorno E. Effects of Empagliflozin on Cardiovascular Outcomes Are[...]